Hemato Oncology Testing Market Size, Share & Trends Analysis Report By Product (Assay Kits & Reagents, Services), By Cancer Type (Leukemia, Lymphoma, MPNs), By Technology, By End-use, By Region, And Segment Forecasts, 2020 - 2027
This report can be delivered to the clients within 72 Business Hours
Hemato Oncology Testing Market Growth & Trends
The global hemato oncology testing market size is expected to reach USD 7.2 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 14.6% from 2020 to 2027. Key drivers for the market include rising incidences of leukemia, lymphoma, myeloproliferative neoplasms, and multiple myeloma. Also, growing collaborations among various major players and research organizations, and an increasing number of research activities conducted by academic and research institutes to develop technologically advanced hemato oncology tests is anticipated to fuel market growth.
The rising prevalence of lymphoma and myeloma is anticipated to propel the market growth during the forecast period. According to a report published by the American Cancer Society, it is estimated that there over 32,270 new cases of multiple myeloma which included 14,740 women and 17,530 men in 2018. Whereas, over 12,830 deaths were recorded in 2018 that included 5,640 women and 7,190 men. Therefore, a rise in the prevalence of the above-mentioned diseases is expected to enhance the usage of hemato oncology testing products.
An increase in the number of product launches is also a major factor contributing to the growth of the market. For instance, in October 2018, MedGenome launched the IGHV gene mutation testing. This test enables health care professionals to access the prognosis of chronic lymphocytic leukemia, and further manage the disease by personalized therapy.
The FDA approval of Invivoscribe’s LeukoStrat companion diagnostic test in conjugation with Novartis’s Rydapt for detection and treatment of AML has been a key factor in the rising number of manufacturers opting for the development of related products. The CE approved assay was launched in 2017, being the first companion diagnostic to be used for the detection of AML. Similarly, in the year 2018, Invivoscribe announced the U.S. FDA's approval for LeukoStrat CDx FLT3 Mutation Assay and XOSPATA, an AML drug manufactured by Astellas Pharma.
Growing collaborations among market players and academic and research organizations are anticipated to boost growth during the forecast period. For instance, in May 2018, Invivoscribe Technologies Inc. collaborated with the American University of Beirut Medical Center (AUBMC) in order to design and build a new center for excellence treatment in the Middle East region for advanced research in hemato oncology testing as well as treatment.
Hemato Oncology Testing Market Report Highlights
Hemato Oncology Testing Market Growth & Trends
The global hemato oncology testing market size is expected to reach USD 7.2 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 14.6% from 2020 to 2027. Key drivers for the market include rising incidences of leukemia, lymphoma, myeloproliferative neoplasms, and multiple myeloma. Also, growing collaborations among various major players and research organizations, and an increasing number of research activities conducted by academic and research institutes to develop technologically advanced hemato oncology tests is anticipated to fuel market growth.
The rising prevalence of lymphoma and myeloma is anticipated to propel the market growth during the forecast period. According to a report published by the American Cancer Society, it is estimated that there over 32,270 new cases of multiple myeloma which included 14,740 women and 17,530 men in 2018. Whereas, over 12,830 deaths were recorded in 2018 that included 5,640 women and 7,190 men. Therefore, a rise in the prevalence of the above-mentioned diseases is expected to enhance the usage of hemato oncology testing products.
An increase in the number of product launches is also a major factor contributing to the growth of the market. For instance, in October 2018, MedGenome launched the IGHV gene mutation testing. This test enables health care professionals to access the prognosis of chronic lymphocytic leukemia, and further manage the disease by personalized therapy.
The FDA approval of Invivoscribe’s LeukoStrat companion diagnostic test in conjugation with Novartis’s Rydapt for detection and treatment of AML has been a key factor in the rising number of manufacturers opting for the development of related products. The CE approved assay was launched in 2017, being the first companion diagnostic to be used for the detection of AML. Similarly, in the year 2018, Invivoscribe announced the U.S. FDA's approval for LeukoStrat CDx FLT3 Mutation Assay and XOSPATA, an AML drug manufactured by Astellas Pharma.
Growing collaborations among market players and academic and research organizations are anticipated to boost growth during the forecast period. For instance, in May 2018, Invivoscribe Technologies Inc. collaborated with the American University of Beirut Medical Center (AUBMC) in order to design and build a new center for excellence treatment in the Middle East region for advanced research in hemato oncology testing as well as treatment.
Hemato Oncology Testing Market Report Highlights
- Lymphoma held a dominant share in terms of revenue in the cancer type segment owing to a rise in the prevalence of Hodgkin and Non-Hodgkin Lymphoma
- The services segment captured the largest market share due to an increase in the incidence rate and rising awareness regarding various treatment therapies such as personalized medicines
- The PCR segment dominated the market in terms of revenue share in 2019 and witnessed exponential growth owing to its ease in use, affordability, the accuracy and efficiency provided, rise in the number of product launches and approval, technological advancements of testing products, and easy availability
- The hospitals segment witnessed exponential growth in 2019 owing to the availability of hemato oncology diagnostic tests and the presence of healthcare professionals to conduct diagnostic tests and monitor the disease
- In North America, the market is expected to witness exponential growth during the forecast period owing to a rise in the prevalence of multiple myeloma, the growing number of awareness and screening campaigns, and the launch of technologically advanced products for the diagnosis of hemato oncology
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources & Third Party Perspectives
1.3.4 Primary Research
1.4 Information analysis
1.4.1 Data Analysis Models
1.5 Market formulation & data visualization
1.6 Data validation & publishing
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
CHAPTER 3 HEMATO ONCOLOGY TESTING MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Ancillary market outlook
3.2 Penetration and Growth Prospect Mapping
3.2.1 User perspective analysis
3.2.1.1 Consumer behavior analysis
3.3 Regulatory Framework
3.3.1 Reimbursement framework
3.3.2 Standards and compliances
3.4 Market Dynamics
3.4.1 Market driver analysis
3.4.1.1 Increasing prevalence of lymphoma & myeloma
3.4.1.2 Growing demand for personalized therapy
3.4.1.3 Availability of advanced molecular techniques for hemato-oncology diagnostics
3.4.1.4 Increasing drug-diagnostics co-development
3.4.2 Market restraint analysis
3.4.2.1 Unfavorable reimbursement scenario
3.4.3 Market opportunities analysis
3.4.3.1 Developing countries provide untapped markets for multinational players
3.4.4 Market challenges analysis
3.4.4.1 Intellectual property rights protection issues
3.5 Hemato Oncology Testing Market Analysis Tools
3.5.1 INDUSTRY ANALYSIS - PORTER’S
3.5.1.1 Supplier Power
3.5.1.2 Buyer Power
3.5.1.3 Substitution Threat
3.5.1.4 Threat from new entrants
3.5.1.5 Competitive Rivalry
3.5.2 PESTEL ANALYSIS
3.5.2.1 Political Landscape
3.5.2.2 Environmental Landscape
3.5.2.3 Social landscape
3.5.2.4 Services landscape
3.5.2.5 Legal Landscape
3.5.3 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
3.5.3.1 Joint ventures
3.5.3.2 Mergers and acquisitions
3.5.3.3 Licensing and partnership
3.5.3.4 Services collaborations
3.5.3.5 Strategic Divestments
CHAPTER 4 HEMATO ONCOLOGY TESTING MARKET - COMPETITIVE ANALYSIS
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company Categorization
4.2.1 List of key distributors and channel partners
4.2.2 Key company market share analysis, 2019
4.3 Public Companies
4.3.1 Company market position analysis
4.4 Private Companies
4.4.1 List of key emerging companies
4.4.2 Regional network map
4.4.3 Company market position analysis
CHAPTER 5 HEMATO ONCOLOGY TESTING MARKET: CANCER TYPE ESTIMATES AND TREND ANALYSIS
5.1 Definition & Scope
5.2 Cancer Type Market Share Analysis, 2019 & 2027
5.3 Segment Dashboard
5.4 Global Hemato Oncology Testing Market, by Cancer Type, 2016 to 2027
5.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
5.6 Leukemia
5.6.1 Leukemia Market, 2016 To 2027 (USD Million)
5.6.1.1 Acute Myeloid Leukemia
5.6.1.1.1 Acute Myeloid Leukemia Market, 2016 To 2027 (USD Million)
5.6.1.2 Acute Lymphocytic Leukemia
5.6.1.2.1 Acute Lymphocytic Leukemia Market, 2016 To 2027 (USD Million)
5.6.1.3 Chronic Lymphocytic Leukemia
5.6.1.3.1 Chronic Lymphocytic Leukemia Market, 2016 To 2027 (USD Million)
5.6.1.4 Chronic Myeloid Leukemia
5.6.1.4.1 Chronic Myeloid Leukemia Market, 2016 To 2027 (USD Million)
5.7 Lymphoma
5.7.1 Lymphoma Market, 2016 To 2027 (USD Million)
5.7.1.1 Non-Hodgkin Lymphoma
5.7.1.1.1 Non-Hodgkin Lymphoma Market, 2016 To 2027 (USD Million)
5.7.1.2 Hodgkin Lymphoma
5.7.1.2.1 Hodgkin Lymphoma Market, 2016 To 2027 (USD Million)
5.8 Myeloproliferative Neoplasms
5.8.1 Myeloproliferative Neoplasms Market, 2016 TO 2027 (USD Million)
5.8.1.1 Polycythemia vera
5.8.1.1.1 Polycythemia vera Market, 2016 to 2027 (USD Million)
5.8.1.2 Essential thrombocythemia
5.8.1.2.1 Essential thrombocythemia Market, 2016 to 2027 (USD Million)
5.8.1.3 Myelofibrosis
5.8.1.3.1 Myelofibrosis Market, 2016 to 2027 (USD Million)
5.9 Other Cancers
5.9.1 OTHER CANCERS MARKET, 2016 TO 2027 (USD Million)
CHAPTER 6 HEMATO ONCOLOGY TESTING MARKET: PRODUCT ESTIMATES AND TREND ANALYSIS
6.1 Definition & Scope
6.2 Product Market Share Analysis, 2019 & 2027
6.3 Segment Dashboard
6.4 Global Hemato Oncology Testing Market, by Product, 2016 to 2027
6.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
6.6 Assay Kits and Reagents
6.6.1 Assay Kits And Reagents Market, 2016 To 2027 (USD Million)
6.7 Services
6.7.1 Services Market, 2016 To 2027 (USD Million)
CHAPTER 7 HEMATO ONCOLOGY TESTING MARKET: TECHNOLOGY ESTIMATES AND TREND ANALYSIS
7.1 Definition & Scope
7.2 Technology Market Share Analysis, 2019 & 2027
7.3 Segment Dashboard
7.4 Global Hemato Oncology Testing Market, by Technology, 2016 to 2027
7.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
7.6 PCR
7.6.1 PCR MARKET, 2016 TO 2027 (USD Million)
7.6.1.1 Real-time qPCR
7.6.1.1.1 Real-time qPCR Market, 2016 to 2027 (USD Million)
7.6.1.2 Digital PCR
7.6.1.2.1 Digital PCR Market, 2016 to 2027 (USD Million)
7.7 IHC
7.7.1 IHC MARKET, 2016 TO 2027 (USD Million)
7.8 NGS
7.8.1 NGS MARKET, 2016 TO 2027 (USD Million)
7.9 Cytogenetics
7.9.1 CYTOGENETICS MARKET, 2016 TO 2027 (USD Million)
7.10 Other Technologies
7.10.1 OTHER TECHNOLOGIES MARKET, 2016 TO 2027 (USD Million)
CHAPTER 8 HEMATO ONCOLOGY TESTING MARKET: END USE ESTIMATES AND TREND ANALYSIS
8.1 Definition & Scope
8.2 End Use Market Share Analysis, 2019 & 2027
8.3 Segment Dashboard
8.4 Global Hemato Oncology Testing Market, by End Use, 2016 to 2027
8.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
8.6 Hospitals
8.6.1 Hospitals Market, 2016 TO 2027 (USD Million)
8.7 Academic & Research Institutes
8.7.1 Academic & Research Institutes Market, 2016 TO 2027 (USD Million)
8.8 Others
8.8.1 Others Market, 2016 TO 2027 (USD Million)
CHAPTER 9 HEMATO ONCOLOGY TESTING MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
9.1 Regional Market Snapshot
9.2 Market Share Analysis by Country, 2019
9.2.1 NORTH AMERICA
9.2.1.1 U.S.
9.2.1.2 Canada
9.2.2 EUROPE
9.2.2.1 U.K.
9.2.2.2 Germany
9.2.2.3 Spain
9.2.2.4 France
9.2.2.5 Italy
9.2.2.6 Russia
9.2.3 LATIN AMERICA
9.2.3.1 Brazil
9.2.3.2 Mexico
9.2.3.3 Argentina
9.2.4 ASIA PACIFIC
9.2.4.1 Japan
9.2.4.2 China
9.2.4.3 India
9.2.4.4 South Korea
9.2.4.5 Australia
9.2.4.6 Singapore
9.2.5 MIDDLE EAST & AFRICA
9.2.5.1 South Africa
9.2.5.2 Saudi Arabia
9.2.5.3 UAE
9.3 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
9.3.1 NORTH AMERICA
9.3.2 EUROPE
9.3.3 LATIN AMERICA
9.3.4 ASIA PACIFIC
9.3.5 MIDDLE EAST & AFRICA
9.4 Market Size & Forecasts, and Trend Analysis, 2016 to 2027
9.4.1 NORTH AMERICA
9.4.1.1 North America Market Size, & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
9.4.1.2 U.S.
9.4.1.2.1 U.S. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.1.2.2 U.S. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.1.2.3 U.S. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.1.2.4 U.S. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.1.3 Canada
9.4.1.3.1 Canada Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.1.3.2 Canada Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.1.3.3 Canada Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.1.3.4 Canada Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.2 EUROPE
9.4.2.1 Europe Market Size, & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
9.4.2.2 U.K.
9.4.2.2.1 U.K. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.2.2.2 U.K. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.2.2.3 U.K. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.2.2.4 U.K. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.2.3 Germany
9.4.2.3.1 Germany Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.2.3.2 Germany Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.2.3.3 Germany Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.2.3.4 Germany Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.2.4 France
9.4.2.4.1 France Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.2.4.2 France Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.2.4.3 France Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.2.4.4 France Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.2.5 Italy
9.4.2.5.1 Italy Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.2.5.2 Italy Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.2.5.3 Italy Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.2.5.4 Italy Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.2.6 Spain
9.4.2.6.1 Spain Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.2.6.2 Spain Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.2.6.3 Spain Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.2.6.4 Spain Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.2.7 Russia
9.4.2.7.1 Russia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.2.7.2 Russia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.2.7.3 Russia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.2.7.4 Russia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.3 ASIA PACIFIC
9.4.3.1 Asia Pacific Market Size, & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
9.4.3.2 Japan
9.4.3.2.1 Japan Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.3.2.2 Japan Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.3.2.3 Japan Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.3.2.4 Japan Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.3.3 China
9.4.3.3.1 China Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.3.3.2 China Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.3.3.3 China Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.3.3.4 China Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.3.4 India
9.4.3.4.1 India Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.3.4.2 India Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.3.4.3 India Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.3.4.4 India Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.3.5 South Korea
9.4.3.5.1 South Korea Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.3.5.2 South Korea Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.3.5.3 South Korea Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.3.5.4 South Korea Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.3.6 Australia
9.4.3.6.1 Australia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.3.6.2 Australia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.3.6.3 Australia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.3.6.4 Australia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.3.7 Singapore
9.4.3.7.1 Singapore Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.3.7.2 Singapore Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.3.7.3 Singapore Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.3.7.4 Singapore Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.4 LATIN AMERICA
9.4.4.1 Latin America Market Size, & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
9.4.4.2 Brazil
9.4.4.2.1 Brazil Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.4.2.2 Brazil Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.4.2.3 Brazil Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.4.2.4 Brazil Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.4.3 Mexico
9.4.4.3.1 Mexico Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.4.3.2 Mexico Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.4.3.3 Mexico Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.4.3.4 Mexico Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.4.4 Argentina
9.4.4.4.1 Argentina Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.4.4.2 Argentina Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.4.4.3 Argentina Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.4.4.4 Argentina Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.5 MIDDLE EAST & AFRICA
9.4.5.1 Middle East & Africa Market Size, & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
9.4.5.2 South Africa
9.4.5.2.1 South Africa Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.5.2.2 South Africa Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.5.2.3 South Africa Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.5.2.4 South Africa Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.5.3 Saudi Arabia
9.4.5.3.1 Saudi Arabia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.5.3.2 Saudi Arabia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.5.3.3 Saudi Arabia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.5.3.4 Saudi Arabia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.5.4 UAE
9.4.5.4.1 UAE Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.5.4.2 UAE Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.5.4.3 UAE Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.5.4.4 UAE Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
CHAPTER 10 COMPANY PROFILES
10.1 Company Profiles
10.1.1 F. HOFFMAN-LA ROCHE LTD.
10.1.1.1 Company overview
10.1.1.2 Financial performance
10.1.1.3 Product benchmarking
10.1.1.4 Strategic initiatives
10.1.2 ABBOTT LABORATORIES
10.1.2.1 Company overview
10.1.2.2 Financial performance
10.1.2.3 Product benchmarking
10.1.2.4 Strategic initiatives
10.1.3 QIAGEN N.V.
10.1.3.1 Company overview
10.1.3.2 Financial performance
10.1.3.3 Product benchmarking
10.1.3.4 Strategic initiatives
10.1.4 THERMO FISHER SCIENTIFIC, INC.
10.1.4.1 Company overview
10.1.4.2 Financial performance
10.1.4.3 Product benchmarking
10.1.4.4 Strategic initiatives
10.1.5 ILLUMINA, INC.
10.1.5.1 Company overview
10.1.5.2 Financial performance
10.1.5.3 Product benchmarking
10.1.5.4 Strategic initiatives
10.1.6 BIO-RAD LABORATORIES, INC.
10.1.6.1 Company overview
10.1.6.2 Financial performance
10.1.6.3 Product benchmarking
10.1.6.4 Strategic initiatives
10.1.7 MOLECULARMD
10.1.7.1 Company overview
10.1.7.2 Financial performance
10.1.7.3 Product benchmarking
10.1.7.4 Strategic initiatives
10.1.8 ARCHERDX, INC.
10.1.8.1 Company overview
10.1.8.2 Financial performance
10.1.8.3 Product benchmarking
10.1.8.4 Strategic initiatives
10.1.9 ARUP LABORATORIES INC.
10.1.9.1 Company overview
10.1.9.2 Financial performance
10.1.9.3 Product benchmarking
10.1.9.4 Strategic initiatives
10.1.10 ASURAGEN, INC.
10.1.10.1 Company overview
10.1.10.2 Financial performance
10.1.10.3 Product benchmarking
10.1.10.4 Strategic initiatives
10.1.11 INVIVOSCRIBE, INC.
10.1.11.1 Company overview
10.1.11.2 Financial performance
10.1.11.3 Product benchmarking
10.1.11.4 Strategic initiatives
10.1.12 ADAPTIVE BIOTECHNOLOGIES
10.1.12.1 Company overview
10.1.12.2 Financial performance
10.1.12.3 Product benchmarking
10.1.12.4 Strategic initiatives
10.1.13 CEPHEID
10.1.13.1 Company overview
10.1.13.2 Financial performance
10.1.13.3 Product benchmarking
10.1.13.4 Strategic initiatives
10.1.14 ENTROGEN, INC.
10.1.14.1 Company overview
10.1.14.2 Financial performance
10.1.14.3 Product benchmarking
10.1.14.4 Strategic initiatives
10.1.15 AMOY DIAGNOSTICS CO., LTD
10.1.15.1 Company overview
10.1.15.2 Financial performance
10.1.15.3 Product benchmarking
10.1.15.4 Strategic initiatives
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources & Third Party Perspectives
1.3.4 Primary Research
1.4 Information analysis
1.4.1 Data Analysis Models
1.5 Market formulation & data visualization
1.6 Data validation & publishing
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
CHAPTER 3 HEMATO ONCOLOGY TESTING MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Ancillary market outlook
3.2 Penetration and Growth Prospect Mapping
3.2.1 User perspective analysis
3.2.1.1 Consumer behavior analysis
3.3 Regulatory Framework
3.3.1 Reimbursement framework
3.3.2 Standards and compliances
3.4 Market Dynamics
3.4.1 Market driver analysis
3.4.1.1 Increasing prevalence of lymphoma & myeloma
3.4.1.2 Growing demand for personalized therapy
3.4.1.3 Availability of advanced molecular techniques for hemato-oncology diagnostics
3.4.1.4 Increasing drug-diagnostics co-development
3.4.2 Market restraint analysis
3.4.2.1 Unfavorable reimbursement scenario
3.4.3 Market opportunities analysis
3.4.3.1 Developing countries provide untapped markets for multinational players
3.4.4 Market challenges analysis
3.4.4.1 Intellectual property rights protection issues
3.5 Hemato Oncology Testing Market Analysis Tools
3.5.1 INDUSTRY ANALYSIS - PORTER’S
3.5.1.1 Supplier Power
3.5.1.2 Buyer Power
3.5.1.3 Substitution Threat
3.5.1.4 Threat from new entrants
3.5.1.5 Competitive Rivalry
3.5.2 PESTEL ANALYSIS
3.5.2.1 Political Landscape
3.5.2.2 Environmental Landscape
3.5.2.3 Social landscape
3.5.2.4 Services landscape
3.5.2.5 Legal Landscape
3.5.3 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
3.5.3.1 Joint ventures
3.5.3.2 Mergers and acquisitions
3.5.3.3 Licensing and partnership
3.5.3.4 Services collaborations
3.5.3.5 Strategic Divestments
CHAPTER 4 HEMATO ONCOLOGY TESTING MARKET - COMPETITIVE ANALYSIS
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company Categorization
4.2.1 List of key distributors and channel partners
4.2.2 Key company market share analysis, 2019
4.3 Public Companies
4.3.1 Company market position analysis
4.4 Private Companies
4.4.1 List of key emerging companies
4.4.2 Regional network map
4.4.3 Company market position analysis
CHAPTER 5 HEMATO ONCOLOGY TESTING MARKET: CANCER TYPE ESTIMATES AND TREND ANALYSIS
5.1 Definition & Scope
5.2 Cancer Type Market Share Analysis, 2019 & 2027
5.3 Segment Dashboard
5.4 Global Hemato Oncology Testing Market, by Cancer Type, 2016 to 2027
5.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
5.6 Leukemia
5.6.1 Leukemia Market, 2016 To 2027 (USD Million)
5.6.1.1 Acute Myeloid Leukemia
5.6.1.1.1 Acute Myeloid Leukemia Market, 2016 To 2027 (USD Million)
5.6.1.2 Acute Lymphocytic Leukemia
5.6.1.2.1 Acute Lymphocytic Leukemia Market, 2016 To 2027 (USD Million)
5.6.1.3 Chronic Lymphocytic Leukemia
5.6.1.3.1 Chronic Lymphocytic Leukemia Market, 2016 To 2027 (USD Million)
5.6.1.4 Chronic Myeloid Leukemia
5.6.1.4.1 Chronic Myeloid Leukemia Market, 2016 To 2027 (USD Million)
5.7 Lymphoma
5.7.1 Lymphoma Market, 2016 To 2027 (USD Million)
5.7.1.1 Non-Hodgkin Lymphoma
5.7.1.1.1 Non-Hodgkin Lymphoma Market, 2016 To 2027 (USD Million)
5.7.1.2 Hodgkin Lymphoma
5.7.1.2.1 Hodgkin Lymphoma Market, 2016 To 2027 (USD Million)
5.8 Myeloproliferative Neoplasms
5.8.1 Myeloproliferative Neoplasms Market, 2016 TO 2027 (USD Million)
5.8.1.1 Polycythemia vera
5.8.1.1.1 Polycythemia vera Market, 2016 to 2027 (USD Million)
5.8.1.2 Essential thrombocythemia
5.8.1.2.1 Essential thrombocythemia Market, 2016 to 2027 (USD Million)
5.8.1.3 Myelofibrosis
5.8.1.3.1 Myelofibrosis Market, 2016 to 2027 (USD Million)
5.9 Other Cancers
5.9.1 OTHER CANCERS MARKET, 2016 TO 2027 (USD Million)
CHAPTER 6 HEMATO ONCOLOGY TESTING MARKET: PRODUCT ESTIMATES AND TREND ANALYSIS
6.1 Definition & Scope
6.2 Product Market Share Analysis, 2019 & 2027
6.3 Segment Dashboard
6.4 Global Hemato Oncology Testing Market, by Product, 2016 to 2027
6.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
6.6 Assay Kits and Reagents
6.6.1 Assay Kits And Reagents Market, 2016 To 2027 (USD Million)
6.7 Services
6.7.1 Services Market, 2016 To 2027 (USD Million)
CHAPTER 7 HEMATO ONCOLOGY TESTING MARKET: TECHNOLOGY ESTIMATES AND TREND ANALYSIS
7.1 Definition & Scope
7.2 Technology Market Share Analysis, 2019 & 2027
7.3 Segment Dashboard
7.4 Global Hemato Oncology Testing Market, by Technology, 2016 to 2027
7.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
7.6 PCR
7.6.1 PCR MARKET, 2016 TO 2027 (USD Million)
7.6.1.1 Real-time qPCR
7.6.1.1.1 Real-time qPCR Market, 2016 to 2027 (USD Million)
7.6.1.2 Digital PCR
7.6.1.2.1 Digital PCR Market, 2016 to 2027 (USD Million)
7.7 IHC
7.7.1 IHC MARKET, 2016 TO 2027 (USD Million)
7.8 NGS
7.8.1 NGS MARKET, 2016 TO 2027 (USD Million)
7.9 Cytogenetics
7.9.1 CYTOGENETICS MARKET, 2016 TO 2027 (USD Million)
7.10 Other Technologies
7.10.1 OTHER TECHNOLOGIES MARKET, 2016 TO 2027 (USD Million)
CHAPTER 8 HEMATO ONCOLOGY TESTING MARKET: END USE ESTIMATES AND TREND ANALYSIS
8.1 Definition & Scope
8.2 End Use Market Share Analysis, 2019 & 2027
8.3 Segment Dashboard
8.4 Global Hemato Oncology Testing Market, by End Use, 2016 to 2027
8.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
8.6 Hospitals
8.6.1 Hospitals Market, 2016 TO 2027 (USD Million)
8.7 Academic & Research Institutes
8.7.1 Academic & Research Institutes Market, 2016 TO 2027 (USD Million)
8.8 Others
8.8.1 Others Market, 2016 TO 2027 (USD Million)
CHAPTER 9 HEMATO ONCOLOGY TESTING MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
9.1 Regional Market Snapshot
9.2 Market Share Analysis by Country, 2019
9.2.1 NORTH AMERICA
9.2.1.1 U.S.
9.2.1.2 Canada
9.2.2 EUROPE
9.2.2.1 U.K.
9.2.2.2 Germany
9.2.2.3 Spain
9.2.2.4 France
9.2.2.5 Italy
9.2.2.6 Russia
9.2.3 LATIN AMERICA
9.2.3.1 Brazil
9.2.3.2 Mexico
9.2.3.3 Argentina
9.2.4 ASIA PACIFIC
9.2.4.1 Japan
9.2.4.2 China
9.2.4.3 India
9.2.4.4 South Korea
9.2.4.5 Australia
9.2.4.6 Singapore
9.2.5 MIDDLE EAST & AFRICA
9.2.5.1 South Africa
9.2.5.2 Saudi Arabia
9.2.5.3 UAE
9.3 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
9.3.1 NORTH AMERICA
9.3.2 EUROPE
9.3.3 LATIN AMERICA
9.3.4 ASIA PACIFIC
9.3.5 MIDDLE EAST & AFRICA
9.4 Market Size & Forecasts, and Trend Analysis, 2016 to 2027
9.4.1 NORTH AMERICA
9.4.1.1 North America Market Size, & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
9.4.1.2 U.S.
9.4.1.2.1 U.S. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.1.2.2 U.S. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.1.2.3 U.S. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.1.2.4 U.S. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.1.3 Canada
9.4.1.3.1 Canada Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.1.3.2 Canada Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.1.3.3 Canada Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.1.3.4 Canada Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.2 EUROPE
9.4.2.1 Europe Market Size, & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
9.4.2.2 U.K.
9.4.2.2.1 U.K. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.2.2.2 U.K. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.2.2.3 U.K. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.2.2.4 U.K. Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.2.3 Germany
9.4.2.3.1 Germany Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.2.3.2 Germany Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.2.3.3 Germany Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.2.3.4 Germany Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.2.4 France
9.4.2.4.1 France Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.2.4.2 France Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.2.4.3 France Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.2.4.4 France Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.2.5 Italy
9.4.2.5.1 Italy Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.2.5.2 Italy Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.2.5.3 Italy Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.2.5.4 Italy Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.2.6 Spain
9.4.2.6.1 Spain Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.2.6.2 Spain Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.2.6.3 Spain Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.2.6.4 Spain Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.2.7 Russia
9.4.2.7.1 Russia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.2.7.2 Russia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.2.7.3 Russia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.2.7.4 Russia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.3 ASIA PACIFIC
9.4.3.1 Asia Pacific Market Size, & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
9.4.3.2 Japan
9.4.3.2.1 Japan Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.3.2.2 Japan Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.3.2.3 Japan Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.3.2.4 Japan Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.3.3 China
9.4.3.3.1 China Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.3.3.2 China Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.3.3.3 China Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.3.3.4 China Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.3.4 India
9.4.3.4.1 India Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.3.4.2 India Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.3.4.3 India Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.3.4.4 India Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.3.5 South Korea
9.4.3.5.1 South Korea Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.3.5.2 South Korea Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.3.5.3 South Korea Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.3.5.4 South Korea Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.3.6 Australia
9.4.3.6.1 Australia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.3.6.2 Australia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.3.6.3 Australia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.3.6.4 Australia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.3.7 Singapore
9.4.3.7.1 Singapore Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.3.7.2 Singapore Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.3.7.3 Singapore Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.3.7.4 Singapore Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.4 LATIN AMERICA
9.4.4.1 Latin America Market Size, & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
9.4.4.2 Brazil
9.4.4.2.1 Brazil Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.4.2.2 Brazil Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.4.2.3 Brazil Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.4.2.4 Brazil Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.4.3 Mexico
9.4.4.3.1 Mexico Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.4.3.2 Mexico Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.4.3.3 Mexico Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.4.3.4 Mexico Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.4.4 Argentina
9.4.4.4.1 Argentina Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.4.4.2 Argentina Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.4.4.3 Argentina Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.4.4.4 Argentina Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.5 MIDDLE EAST & AFRICA
9.4.5.1 Middle East & Africa Market Size, & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
9.4.5.2 South Africa
9.4.5.2.1 South Africa Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.5.2.2 South Africa Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.5.2.3 South Africa Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.5.2.4 South Africa Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.5.3 Saudi Arabia
9.4.5.3.1 Saudi Arabia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.5.3.2 Saudi Arabia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.5.3.3 Saudi Arabia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.5.3.4 Saudi Arabia Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
9.4.5.4 UAE
9.4.5.4.1 UAE Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Cancer Type, 2016 to 2027 (USD Million)
9.4.5.4.2 UAE Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Product, 2016 to 2027 (USD Million)
9.4.5.4.3 UAE Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By Technology, 2016 to 2027 (USD Million)
9.4.5.4.4 UAE Hemato Oncology Testing Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2027 (USD Million)
CHAPTER 10 COMPANY PROFILES
10.1 Company Profiles
10.1.1 F. HOFFMAN-LA ROCHE LTD.
10.1.1.1 Company overview
10.1.1.2 Financial performance
10.1.1.3 Product benchmarking
10.1.1.4 Strategic initiatives
10.1.2 ABBOTT LABORATORIES
10.1.2.1 Company overview
10.1.2.2 Financial performance
10.1.2.3 Product benchmarking
10.1.2.4 Strategic initiatives
10.1.3 QIAGEN N.V.
10.1.3.1 Company overview
10.1.3.2 Financial performance
10.1.3.3 Product benchmarking
10.1.3.4 Strategic initiatives
10.1.4 THERMO FISHER SCIENTIFIC, INC.
10.1.4.1 Company overview
10.1.4.2 Financial performance
10.1.4.3 Product benchmarking
10.1.4.4 Strategic initiatives
10.1.5 ILLUMINA, INC.
10.1.5.1 Company overview
10.1.5.2 Financial performance
10.1.5.3 Product benchmarking
10.1.5.4 Strategic initiatives
10.1.6 BIO-RAD LABORATORIES, INC.
10.1.6.1 Company overview
10.1.6.2 Financial performance
10.1.6.3 Product benchmarking
10.1.6.4 Strategic initiatives
10.1.7 MOLECULARMD
10.1.7.1 Company overview
10.1.7.2 Financial performance
10.1.7.3 Product benchmarking
10.1.7.4 Strategic initiatives
10.1.8 ARCHERDX, INC.
10.1.8.1 Company overview
10.1.8.2 Financial performance
10.1.8.3 Product benchmarking
10.1.8.4 Strategic initiatives
10.1.9 ARUP LABORATORIES INC.
10.1.9.1 Company overview
10.1.9.2 Financial performance
10.1.9.3 Product benchmarking
10.1.9.4 Strategic initiatives
10.1.10 ASURAGEN, INC.
10.1.10.1 Company overview
10.1.10.2 Financial performance
10.1.10.3 Product benchmarking
10.1.10.4 Strategic initiatives
10.1.11 INVIVOSCRIBE, INC.
10.1.11.1 Company overview
10.1.11.2 Financial performance
10.1.11.3 Product benchmarking
10.1.11.4 Strategic initiatives
10.1.12 ADAPTIVE BIOTECHNOLOGIES
10.1.12.1 Company overview
10.1.12.2 Financial performance
10.1.12.3 Product benchmarking
10.1.12.4 Strategic initiatives
10.1.13 CEPHEID
10.1.13.1 Company overview
10.1.13.2 Financial performance
10.1.13.3 Product benchmarking
10.1.13.4 Strategic initiatives
10.1.14 ENTROGEN, INC.
10.1.14.1 Company overview
10.1.14.2 Financial performance
10.1.14.3 Product benchmarking
10.1.14.4 Strategic initiatives
10.1.15 AMOY DIAGNOSTICS CO., LTD
10.1.15.1 Company overview
10.1.15.2 Financial performance
10.1.15.3 Product benchmarking
10.1.15.4 Strategic initiatives
LIST OF TABLES
Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies/product disruptors/innovators
Table 3 North America Hemato Oncology Testing Market, by countries, 2016 - 2027 (USD Million)
Table 4 North America Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 5 North America Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 6 North America Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 7 North America Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 8 U.S. Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 9 U.S. Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 10 U.S. Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 11 U.S. Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 12 Canada Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 13 Canada Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 14 Canada Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 15 Canada Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 16 Europe Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 17 Europe Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 18 Europe Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 19 Europe Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 20 U.K. Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 21 U.K. Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 22 U.K. Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 23 U.K. Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 24 Germany Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 25 Germany Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 26 Germany Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 27 Germany Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 28 France Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 29 France Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 30 France Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 31 France Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 32 Italy Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 33 Italy Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 34 Italy Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 35 Italy Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 36 Spain Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 37 Spain Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 38 Spain Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 39 Spain Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 40 Russia Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 41 Russia Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 42 Russia Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 43 Russia Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 44 Asia Pacific Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 45 Asia Pacific Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 46 Asia Pacific Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 47 Asia Pacific Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 48 Japan Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 49 Japan Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 50 Japan Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 51 Japan Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 52 China Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 53 China Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 54 China Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 55 India Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 56 India Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 57 India Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 58 India Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 59 South Korea Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 60 South Korea Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 61 South Korea Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 62 South Korea Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 63 Australia Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 64 Australia Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 65 Australia Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 66 Australia Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 67 Singapore Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 68 Singapore Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 69 Singapore Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 70 Singapore Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 71 Latin America Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 72 Latin America Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 73 Latin America Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 74 Latin America Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 75 Brazil Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 76 Brazil Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 77 Brazil Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 78 Brazil Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 79 Mexico Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 80 Mexico Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 81 Mexico Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 82 Mexico Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 83 Argentina Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 84 Argentina Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 85 Argentina Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 86 Argentina Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 87 MEA Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 88 MEA Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 89 MEA Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 90 MEA Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 91 South Africa Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 92 South Africa Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 93 South Africa Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 94 South Africa Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 95 Saudi Arabia Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 96 Saudi Arabia Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 97 Saudi Arabia Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 98 Saudi Arabia Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 99 UAE Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 100 UAE Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 101 UAE Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 102 UAE Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies/product disruptors/innovators
Table 3 North America Hemato Oncology Testing Market, by countries, 2016 - 2027 (USD Million)
Table 4 North America Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 5 North America Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 6 North America Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 7 North America Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 8 U.S. Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 9 U.S. Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 10 U.S. Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 11 U.S. Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 12 Canada Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 13 Canada Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 14 Canada Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 15 Canada Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 16 Europe Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 17 Europe Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 18 Europe Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 19 Europe Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 20 U.K. Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 21 U.K. Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 22 U.K. Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 23 U.K. Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 24 Germany Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 25 Germany Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 26 Germany Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 27 Germany Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 28 France Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 29 France Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 30 France Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 31 France Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 32 Italy Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 33 Italy Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 34 Italy Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 35 Italy Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 36 Spain Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 37 Spain Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 38 Spain Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 39 Spain Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 40 Russia Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 41 Russia Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 42 Russia Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 43 Russia Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 44 Asia Pacific Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 45 Asia Pacific Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 46 Asia Pacific Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 47 Asia Pacific Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 48 Japan Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 49 Japan Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 50 Japan Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 51 Japan Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 52 China Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 53 China Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 54 China Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 55 India Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 56 India Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 57 India Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 58 India Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 59 South Korea Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 60 South Korea Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 61 South Korea Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 62 South Korea Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 63 Australia Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 64 Australia Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 65 Australia Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 66 Australia Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 67 Singapore Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 68 Singapore Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 69 Singapore Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 70 Singapore Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 71 Latin America Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 72 Latin America Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 73 Latin America Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 74 Latin America Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 75 Brazil Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 76 Brazil Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 77 Brazil Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 78 Brazil Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 79 Mexico Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 80 Mexico Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 81 Mexico Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 82 Mexico Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 83 Argentina Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 84 Argentina Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 85 Argentina Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 86 Argentina Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 87 MEA Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 88 MEA Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 89 MEA Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 90 MEA Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 91 South Africa Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 92 South Africa Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 93 South Africa Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 94 South Africa Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 95 Saudi Arabia Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 96 Saudi Arabia Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 97 Saudi Arabia Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 98 Saudi Arabia Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
Table 99 UAE Hemato Oncology Testing Market, by cancer type, 2016 - 2027 (USD Million)
Table 100 UAE Hemato Oncology Testing Market, by product, 2016 - 2027 (USD Million)
Table 101 UAE Hemato Oncology Testing Market, by technology, 2016 - 2027 (USD Million)
Table 102 UAE Hemato Oncology Testing Market, by end use, 2016 - 2027 (USD Million)
LIST OF FIGURES
Fig. 1 Hemato Oncology Testing Market Segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain based sizing & forecasting
Fig. 7 Hemato Oncology Testing Market Snapshot (2019)
Fig. 8 Hemato Oncology Testing Market: Segment Snapshot (2019)
Fig. 9 Competitive Insights (2019)
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Hemato Oncology Testing Market: Driver Impact
Fig. 15 Hemato Oncology Testing Market: Restraint Impact
Fig. 16 Hemato Oncology Testing Market: Opportunities Impact
Fig. 17 Hemato Oncology Testing Market: Challenges Impact
Fig. 18 Porter’s Five Forces Analysis
Fig. 19 SWOT Analysis, By Factor (Political & Legal, Economic and technological)
Fig. 20 Strategic alliance analysis
Fig. 21 Recent developments & impact analysis, by key market participants
Fig. 22 Key company market share analysis, 2019
Fig. 23 Company market share/ranking, by region
Fig. 24 Company market position analysis
Fig. 25 Cancer type market share analysis, 2019 & 2027
Fig. 26 Segment dashboard
Fig. 27 Global Hemato Oncology Testing Market, by Cancer Type, 2016 - 2027 (USD Million)
Fig. 28 Global Leukemia Market, 2016 - 2027 (USD Million)
Fig. 29 Global Acute Myeloid Leukemia Market, 2016 - 2027 (USD Million)
Fig. 30 Global Acute Lymphocytic Leukemia Market, 2016 - 2027 (USD Million)
Fig. 31 Global Chronic Lymphocytic Leukemia Market, 2016 - 2027 (USD Million)
Fig. 32 Global Chronic Myeloid Leukemia Market, 2016 - 2027 (USD Million)
Fig. 33 Global Lymphoma Market, 2016 - 2027 (USD Million)
Fig. 34 Global Non-Hodgkin Lymphoma Market, 2016 - 2027 (USD Million)
Fig. 35 Global Hodgkin Lymphoma Market, 2016 - 2027 (USD Million)
Fig. 36 Global Myeloproliferative Neoplasms Market, 2016 - 2027 (USD Million)
Fig. 37 Global Polycythemia vera Market, 2016 - 2027 (USD Million)
Fig. 38 Global Essential thrombocythemia Market, 2016 - 2027 (USD Million)
Fig. 39 Global Myelofibrosis Market, 2016 - 2027 (USD Million)
Fig. 40 Global Others Cancers Market, 2016 - 2027 (USD Million)
Fig. 41 Global Hemato Oncology Testing Market, by Product, 2016 - 2027 (USD Million)
Fig. 42 Global Assay Kits and Reagents Market, 2016 - 2027 (USD Million)
Fig. 43 Global Services Market, 2016 - 2027 (USD Million)
Fig. 44 Global Hemato Oncology Testing Market, by Technology, 2016 - 2027 (USD Million)
Fig. 45 Global PCR Market, 2016 - 2027 (USD Million)
Fig. 46 Global Real-time qPCR Market, 2016 - 2027 (USD Million)
Fig. 47 Global Digital PCR Market, 2016 - 2027 (USD Million)
Fig. 48 Global IHC Market, 2016 - 2027 (USD Million)
Fig. 49 Global NGS Market, 2016 - 2027 (USD Million)
Fig. 50 Global Cytogenetics Market, 2016 - 2027 (USD Million)
Fig. 51 Global Others Technologies Market, 2016 - 2027 (USD Million)
Fig. 52 Global Hemato Oncology Testing Market, by End-Use, 2016 - 2027 (USD Million)
Fig. 53 Global Hospitals Market, 2016 - 2027 (USD Million)
Fig. 54 Global Academic & Research Institutes Market, 2016 - 2027 (USD Million)
Fig. 55 Global Others Market, 2016 - 2027 (USD Million)
Fig. 56 Hemato Oncology Testing Market Snapshot
Fig. 57 North America Hemato Oncology Testing Market Share Analysis by country, 2019
Fig. 58 Europe Hemato Oncology Testing Market Share Analysis by country, 2019
Fig. 59 Asia Pacific Hemato Oncology Testing Market Share Analysis by country, 2019
Fig. 60 Latin America Hemato Oncology Testing Market Share Analysis by country, 2019
Fig. 61 Middle East and Africa Hemato Oncology Testing Market Share Analysis by country, 2019
Fig. 62 North America SWOT Analysis, by factor (political & legal, economic and technological)
Fig. 63 Europe SWOT Analysis, by factor (political & legal, economic and technological)
Fig. 64 Asia Pacific SWOT Analysis, by factor (political & legal, economic and technological)
Fig. 65 Latin America SWOT Analysis, by factor (political & legal, economic and technological)
Fig. 66 Middle East and Africa SWOT Analysis, by factor (political & legal, economic and technological)
Fig. 1 Hemato Oncology Testing Market Segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain based sizing & forecasting
Fig. 7 Hemato Oncology Testing Market Snapshot (2019)
Fig. 8 Hemato Oncology Testing Market: Segment Snapshot (2019)
Fig. 9 Competitive Insights (2019)
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Hemato Oncology Testing Market: Driver Impact
Fig. 15 Hemato Oncology Testing Market: Restraint Impact
Fig. 16 Hemato Oncology Testing Market: Opportunities Impact
Fig. 17 Hemato Oncology Testing Market: Challenges Impact
Fig. 18 Porter’s Five Forces Analysis
Fig. 19 SWOT Analysis, By Factor (Political & Legal, Economic and technological)
Fig. 20 Strategic alliance analysis
Fig. 21 Recent developments & impact analysis, by key market participants
Fig. 22 Key company market share analysis, 2019
Fig. 23 Company market share/ranking, by region
Fig. 24 Company market position analysis
Fig. 25 Cancer type market share analysis, 2019 & 2027
Fig. 26 Segment dashboard
Fig. 27 Global Hemato Oncology Testing Market, by Cancer Type, 2016 - 2027 (USD Million)
Fig. 28 Global Leukemia Market, 2016 - 2027 (USD Million)
Fig. 29 Global Acute Myeloid Leukemia Market, 2016 - 2027 (USD Million)
Fig. 30 Global Acute Lymphocytic Leukemia Market, 2016 - 2027 (USD Million)
Fig. 31 Global Chronic Lymphocytic Leukemia Market, 2016 - 2027 (USD Million)
Fig. 32 Global Chronic Myeloid Leukemia Market, 2016 - 2027 (USD Million)
Fig. 33 Global Lymphoma Market, 2016 - 2027 (USD Million)
Fig. 34 Global Non-Hodgkin Lymphoma Market, 2016 - 2027 (USD Million)
Fig. 35 Global Hodgkin Lymphoma Market, 2016 - 2027 (USD Million)
Fig. 36 Global Myeloproliferative Neoplasms Market, 2016 - 2027 (USD Million)
Fig. 37 Global Polycythemia vera Market, 2016 - 2027 (USD Million)
Fig. 38 Global Essential thrombocythemia Market, 2016 - 2027 (USD Million)
Fig. 39 Global Myelofibrosis Market, 2016 - 2027 (USD Million)
Fig. 40 Global Others Cancers Market, 2016 - 2027 (USD Million)
Fig. 41 Global Hemato Oncology Testing Market, by Product, 2016 - 2027 (USD Million)
Fig. 42 Global Assay Kits and Reagents Market, 2016 - 2027 (USD Million)
Fig. 43 Global Services Market, 2016 - 2027 (USD Million)
Fig. 44 Global Hemato Oncology Testing Market, by Technology, 2016 - 2027 (USD Million)
Fig. 45 Global PCR Market, 2016 - 2027 (USD Million)
Fig. 46 Global Real-time qPCR Market, 2016 - 2027 (USD Million)
Fig. 47 Global Digital PCR Market, 2016 - 2027 (USD Million)
Fig. 48 Global IHC Market, 2016 - 2027 (USD Million)
Fig. 49 Global NGS Market, 2016 - 2027 (USD Million)
Fig. 50 Global Cytogenetics Market, 2016 - 2027 (USD Million)
Fig. 51 Global Others Technologies Market, 2016 - 2027 (USD Million)
Fig. 52 Global Hemato Oncology Testing Market, by End-Use, 2016 - 2027 (USD Million)
Fig. 53 Global Hospitals Market, 2016 - 2027 (USD Million)
Fig. 54 Global Academic & Research Institutes Market, 2016 - 2027 (USD Million)
Fig. 55 Global Others Market, 2016 - 2027 (USD Million)
Fig. 56 Hemato Oncology Testing Market Snapshot
Fig. 57 North America Hemato Oncology Testing Market Share Analysis by country, 2019
Fig. 58 Europe Hemato Oncology Testing Market Share Analysis by country, 2019
Fig. 59 Asia Pacific Hemato Oncology Testing Market Share Analysis by country, 2019
Fig. 60 Latin America Hemato Oncology Testing Market Share Analysis by country, 2019
Fig. 61 Middle East and Africa Hemato Oncology Testing Market Share Analysis by country, 2019
Fig. 62 North America SWOT Analysis, by factor (political & legal, economic and technological)
Fig. 63 Europe SWOT Analysis, by factor (political & legal, economic and technological)
Fig. 64 Asia Pacific SWOT Analysis, by factor (political & legal, economic and technological)
Fig. 65 Latin America SWOT Analysis, by factor (political & legal, economic and technological)
Fig. 66 Middle East and Africa SWOT Analysis, by factor (political & legal, economic and technological)
